Pharmaceutical

Canada NewsWire BOSTON and BEIJING, Jan. 26, 2021/CNW/ —Eucure Biopharma, a subsidiary of Biocytogen, announced the first patient enrollment for

Eisai to Present Abstracts on Lenvatinib at 2021 Gastrointestinal Cancers Symposium TOKYO, Jan 12, 2021 – (JCN Newswire) – Eisai

Bronya Climate Shield Lab Results Indicate Fire Retardant Solution to OSB I-Joist Manufacturer  Toronto, Ontario–(Newsfile Corp. – January 7, 2021)

Canada NewsWire VANCOUVER, BC,Dec. 24, 2020/CNW/ –Mountain Valley MD Holdings Inc.(the “Company” or “MVMD“) (CSE: MVMD) (FRA: 20MP) is pleased

LAVAL, QC, and CAMBRIDGE, England, Dec. 15, 2020/CNW Telbec/ – Liminal BioSciences Inc. (Nasdaq: LMNL) (“Liminal BioSciences” or the “Company”),

VANCOUVER, BC,Dec. 10, 2020/CNW/ –Mountain Valley MD Holdings Inc.(the “Company” or “MVMD“) (CSE: MVMD) (FRA: 20MP) is pleased to announce

Canada NewsWire WALTHAM, Mass., Dec. 1, 2020 Merck executes option to license its first immunotherapy candidate from the companies’ 2018

Canada NewsWire VICTORIA, BC, Nov. 25, 2020 VICTORIA, BC,Nov. 25, 2020/CNW/ – IMMUNOPRECISE ANTIBODIES LTD. (the “Company” or “IPA”) (TSXV:

Canada NewsWire NYON, Switzerland, Nov. 24, 2020 NYON, Switzerland, Nov. 24, 2020/CNW/ — MedAlliance has announced completion of patient enrolment

Canada NewsWire SAN FRANCISCO and NORTH CHICAGO, Ill., Nov. 25, 2020 SAN FRANCISCOandNORTH CHICAGO, Ill.,Nov. 25, 2020/CNW/ —PostEra, a biotechnology